Genevieve C. Kendall PhD

Genevieve Kendall, Ph.D., is a principal investigator in the Center for Childhood Cancer and Blood Diseases and an assistant professor of Pediatrics at The Ohio State University College of Medicine. Dr. Kendall and her lab focus on developing basic and translational models of pediatric sarcomas—devastating and aggressive solid tumors with limited treatment options. Specifically, they study fusion-driven rhabdomyosarcoma, which is thought to arise from problems during skeletal muscle development. They use cell culture and transgenic zebrafish systems to understand the underlying biology of the disease and identify molecular targets for treatments and ultimately improve outcomes for children with cancer.

Dr. Kendall received her bachelor’s degree in Cell and Molecular Biology at Texas Tech University, where she was a Howard Hughes Medical Institute Undergraduate Research Fellow. She obtained her doctorate degree in Molecular Biology at the University of California, Los Angeles (UCLA), before focusing on pediatric oncology during her postdoctoral studies working with James Amatruda, MD, Ph.D., at UT Southwestern Medical Center.